In the ED, vitals were T 98.4 HR 82 BP 127/99 RR 22 O2 sat 100% by written documentation although by verbal report O2 sats were in the low 90s and she was diffusely wheezy on exam.
CXR did not reveal e/o CHF nor infiltrates and CT chest did not show consolidation.
CT abdomen showed liver mass causing mass effect on IVC, but no evidence of IVC thrombosis.
CTA chest showed second order left lower lobe PE of doubtful clinical significance.
She had diarrhea upon return from a recent cruise, but C. diff and stool studies were negative.
CHF, diastolic dysfunction 13.
Psoriasis 14.
She quit smoking 2 years ago--smoked 1 ppd X 40 years.
Physical Exam: Vitals: T 97.3 axillary BP 113/63 HR 96 a. fib RR 20 O2 sat 95% RA (100% 4L NC) Gen: NAD, pleasant, interactive, appears mildly SOB, not using accessory resp.
In the ED she was requiring continuous nebulizers and was transferred to the [**Hospital Unit Name 153**] for further management.
Although she was recently diagnosed with PE, CTA chest upon admission did not reveal propagation, but rather showed stable second order chronic PE in the left lower lobe and this was thought unlikely to be contributing to her symptoms.
Additionally, there were no infiltrates on CXR nor CT chest.
AFP on [**2130-1-20**] was found to be [**Numeric Identifier 110679**] and on [**2129-2-3**] was [**Numeric Identifier 110680**].
Recent CT abdomen showed liver mass causing mass effect on IVC, but no evidence of IVC thrombosis.
Cardiac enzymes originally revealed MB index slightly elevated at 6.5 and troponin also up at 0.05, but with full cycling, troponin decreased to 0.02 and index was no longer significant.
EKG did not reveal any ischemic changes and she denied any symptoms of chest pain.
She was continued on aspirin, BB was restarted when blood pressure could tolerate and statin was held in the setting of her hepatic malignancy.
# CHF:  Although BNP was elevated to 8340, she had no evidence of fluid overload on exam nor on CXR.
# ARF:  Creatinine elevated to 1.2 from baseline 0.7-0.9.
INR was 4.5 in the ED on 3mg daily coumadin dose.
CTA in ED revealed small PE which was thought unlikely clinically significant given not hypoxic.
Hct remained stable.
Albuterol-Ipratropium 103-18 mcg/Actuation Aerosol 1-2 puffs Q4H 4.
